forum
DCAL Share Price Target
Dishman Carbogen Amcis Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
DCAL Share Price *
180.85 -1.4 (-0.77%)
* (quote may be delayed)
DCAL Share Price Forecast - Consensus
| No. of reports in last year | 8 |
| No. of analysts | 4 |
| Average Consensus Forecast | 373.50 |
| Consensus Potential | 50.79% |
DCAL Share Price Target - Broker Reports - 2019
HDFC Securities
19-Aug-19
Price @ Call: 178
Target: 355
BUY
We maintain a BUY on DCAL following a disappointing quarter. Our TP is revised to Rs 355 (15x FY21E EPS) with a 5% cut to FY21E EPS (higher depreciation expectation).
Nirmal Bang
16-Aug-19
Price @ Call: 178.12
Target: 344
BUY
Despite a weak quarter, the company has maintained its full year guidance of 10% growth in revenue and EBITDA margin in the range of 26%-27%. Our forecasts assume revenue and EBITDA margin slightly above the guidance range. However, considering the market conditions, we lower our target valuation multiple on DCAL to 9x EV/EBITDA from 11x EV/EBITDA and arrive at a target price (TP) of Rs344.
AnandRathi
20-May-19
Price @ Call: 215.75
Target: 390
BUY
We expect revenue and PAT CAGRs over FY19-21 of respectively ~12% and ~19%. We maintain a Buy, with a higher target of Rs 390 based on FY21e EPS.
HDFC Securities
28-Jan-19
Price @ Call: 216.25
Target: 380
BUY
Nirmal Bang
28-Jan-19
Price @ Call: 216.25
Target: 429
BUY
Karvy Stock Broking
28-Jan-19
Price @ Call: 216.25
Target: 320
BUY
DCAL Share Price Target - Broker Reports - 2018
HDFC Securities
7-Dec-18
Price @ Call: 237.12
Target: 355
BUY
HDFC Securities
1-Oct-18
Price @ Call: 236.54
Target: 415
BUY
AnandRathi
31-Jul-18
Price @ Call: 261.3
Target: 380
BUY
DCAL Share Price Target - Broker Reports - 2017
HDFC Securities
26-Dec-17
Price @ Call: 317.56
Target: 435
BUY
Nirmal Bang
13-Nov-17
Price @ Call: 293.75
Target: 410
BUY